Pharma Focus Asia
KP - Sustainable Packaging Solutions

Sanofi and Lonza to Build New US$285 million Swiss Biologics Facility


Sanofi, French drugmaker and Swiss manufacturer Lonza will invest US$285 million to build a new large-scale biologics facility that will produce monoclonal antibodies by 2020.


The companies will build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland.

The facility will be established through a 50-50 joint venture and will be located in Visp, Switzerland.

By contrast to most drugs that are chemically synthesized, many biologics are produced using living cells. They are seen as a promising answer in areas such as cardiovascular, neurology or cancer treatments.

The facility will provide means to treat a variety of medical illness and conditions that have no other treatments available. They are also more expensive than traditional products.

Approximately sixty percent of Swiss biologics facility’s pipeline is made up of biologics, including monoclonal antibodies, dedicated to key disease areas such as cardiovascular, immunology and inflammation, neurology and oncology.

The construction of this facility would create 200 jobs in the process.

Sanofi will be capable to react quickly to fluctuations in demand in a short timeframe, strengthening their competence to launch high-quality, next generation biologic medicines and ensure consistent access for patients.


NameSanofi and Lonza
LocationVisp, Switzerland
TypeNew Construction
Estimated CostUS$285 million
Parties InvolvedSanofi and Lonza
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?